Related Experiment Videos

Empyema in infancy and childhood

R Padmini1, S Srinivasan, R K Puri

  • 1Department of Pediatrics, JIPMER, Pondicherry.

Indian Pediatrics
|May 1, 1990
PubMed

Insights

This study on empyema found Staphylococcus aureus as a common cause. Combination antibiotic therapy, particularly cloxacillin and gentamicin, improved outcomes, with most patients recovering well.

Area of Science:

  • Pediatric Infectious Diseases
  • Thoracic Surgery
  • Clinical Microbiology

Background:

  • Empyema, a serious thoracic infection, presents diagnostic and therapeutic challenges, particularly in pediatric populations.
  • Understanding causative organisms and treatment efficacy is crucial for improving patient outcomes.

Purpose of the Study:

  • To investigate the incidence, causative organisms, treatment responses, and prognostic factors of empyema in a pediatric cohort.
  • To compare the effectiveness of different antibiotic regimens in managing pediatric empyema.

Main Methods:

  • Retrospective analysis of 108 pediatric empyema cases over an 18-month period.
  • Identification of causative pathogens, primarily Staphylococcus aureus.
  • Evaluation of treatment outcomes based on antibiotic combinations (cloxacillin/gentamicin vs. penicillin/gentamicin) and need for interventions like intercostal drainage.

Main Results:

  • Empyema incidence was 2.17%, with Staphylococcus aureus being the most frequent pathogen (17.6%).
  • Cloxacillin and gentamicin combination showed superior response compared to crystalline penicillin and gentamicin.
  • Only 30.3% required prolonged intercostal drainage; mortality rate was 12.1%.
  • Factors influencing recovery included age, antibiotic choice, and nutritional status.

Conclusions:

  • Early diagnosis and appropriate antibiotic therapy, considering pathogen profile and patient factors, are key to successful empyema management.
  • The combination of cloxacillin and gentamicin offers a promising therapeutic option for pediatric empyema.
  • Further research into risk factors and long-term sequelae, such as bronchiectasis, is warranted.

Related Concept Videos